Prof. Dr. Stefan Glück


Prof. Dr. Stefan Glück

Consulting Editor: Stefan Glück (MD, PhD)

Vice President Global Medical Affairs, Breast, Ovarian, Bladder Cancer and Immunotherapy, Celgene Corporation, Summit, NJ, USA

Stefan Glück, MD, PhD, is Vice President, Global Medical Affairs at Celgene Corporation since October 2014; prior to that he was until September 2014 a Sylvester Professor in the Department of Medicine, Miller School of Medicine at the University of Miami in Miami, Florida. He is a medical oncologist with a focus on breast cancer. From 2003–2008, he was the Clinical Director of the Braman Family Breast Cancer Institute, from January 2009 to December 2010 assistant Director of the Sylvester Comprehensive Cancer Center and Associate Chief, Division Hematology and Medical Oncology. Dr. Glück was presented the America’s Top Oncologists 2008 award from Consumers’ Research Council of America; he also received the Best Doctors in America honor in since 2006, and has annually earned that prestige every year, including in 2014; this award was warranted after less than 3 years of working in the United States. Before his move to Miami, Dr Glück was Director, Southern Alberta Breast Cancer Program at the Tom Baker Cancer Center, a Professor in the departments of oncology, medicine, pharmacology, and therapeutics at the University of Calgary in Alberta, Canada, and Deputy Head, Department of Oncology at the University of Calgary. Dr Glück completed his medical studies at the Free University of West Berlin, Germany. The internship in Berlin was followed by residency in internal medicine and fellowship in hematology at the Heinrich Heine Universität in Düsseldorf, Germany, and a medical oncology and bone marrow transplant fellowship at the Princess Margaret Hospital, University of Toronto in Canada.

As VP, Global Medical Affairs, he oversees Breast, Ovarian and Bladder cancer activities worldwide for the Celgene Corporation as well as the Immuno-Oncology Program.

His interest has been in clinical trials in breast cancer and he has been a PI of 37 clinical studies in breast cancer in Miami, and investigator in numerous scientific, translational projects. Dr Glück is a member of such prestigious professional organizations, as the American Society of Clinical Oncology, the European Society for Medical Oncology, the American and European Association of Cancer Research, and the International Association for Breast Cancer Research. He is a reviewer of numerous journals e.g.: Journal of Clinical Oncology, European Journal of Cancer, Lancet Oncology, Lancet, Breast Cancer Research, The Oncologist, The Breast Journal, Clinical Breast Cancer and many others. He is Medical associate Editor of Breast Cancer Research and Treatment and Co-Editor in Chief of Journal of Carcinogenesis and Clinical Communications Oncology that he co founded in 2014. He has authored or co-authored over 250 articles. In addition, Dr Glück has written or co-written a number of book chapters and numerous journal abstracts, and he has presented more than 350 papers at national and international meetings.